Table 2.
Examples | Reported in liver diseases | References | |
---|---|---|---|
DAMPs | HMGB-1 | AILI, I/R injury, NASH | (31–36) |
HSP-70 | AILI | (37, 38) | |
Bile acids | Cholestatic liver disease | (39–43) | |
Histones | I/R injury | (44) | |
FFAs | NASH | (45) | |
mtDNA | NASH | (45) | |
PAMPs | Bacteria-derived products, e.g. LPS | ALD, NASH | (46–49) |
Hepatitis virus, e.g. HBV, HCV, HEV | Hepatitis virus infection | (50–52) | |
Phagocytosis of cellular debris | Apoptotic cells | LPS/D-gal-induced hepatitis, CCL4-induced liver fibrosis, ALD | (53–55) |
DAMPs, danger-associated molecular patterns; PAMPs, pathogen-associated molecular patterns; HMGB-1, high mobility group box 1; HSP-70, heat shock protein 70; FFAs, free fatty acids; mtDNA, mitochondrial DNA; LPS, Lipopolysaccharides; HBV, hepatitis B virus; HCV, hepatitis C virus; HEV, hepatitis E virus; AILI, Acetaminophen-induced liver injury; I/R, Ischemia/Reperfusion; NASH, Non-alcoholic steatohepatitis; ALD, Alcoholic liver disease.